Branchio-oto-renal (BOR) syndrome is an autosomal dominant disorder, characterised by the association of branchial, otic and renal anomalies with variable degrees of severity. We have recently identified EYA1, a human homologue of the Drosophila eyes absent gene, as the gene underlying this syndrome. The products of both genes share a highly conserved 271 amino acid C-terminal region (eyaHR). The eyaHR was also found in the products of two other human genes (EYA2 and EYA3), demonstrating the existence of a novel gene family. We report here on the complete genomic structure of EYA1. This gene consists of 16 coding exons and extends over 156 kb. It encodes various alternatively spliced transcripts differing only in their 5′ regions. Sequence analysis of the entire EYA1 coding region was performed for 20 unrelated patients affected by BOR syndrome, and six novel mutations were identified. Among these mutations, two are missense mutations, highlighting amino acid residues essential for the function of the EYA1 protein, and one mutation comprises a de novo Alu insertion into an exon. This insertion presumably occurs by retrotransposition, and the mobile Alu element has a poly(A) tail that is unstable throughout generations. To date, 14 mutations have been detected in BOR patients, all of which are different. However, all the mutations are located within or in the immediate vicinity of the eyaHR; the significance of this clustering is discussed.
INTRODUCTION
Branchio-oto-renal (BOR) syndrome, first described by Melnick et al. , is characterised by the association of branchial anomalies (i.e. pre-auricular pits and branchial fistulae or cysts), otic anomalies affecting the outer, middle and/or inner ear that frequently lead to hearing loss (sensorineural, conductive or mixed) and a wide spectrum of renal anomalies ranging from mild hypoplasia to lethal bilateral renal aplasia (1) . The clinical features of BOR syndrome are indicative of an early developmental defect. This syndrome is transmitted as an autosomal dominant disorder with high but incomplete penetrance and variable expressivity (2) (3) (4) . Hearing loss is the most constant feature of BOR syndrome, detected in 93% of affected individuals. This syndrome accounts for 2% of profoundly deaf children (5) .
The gene responsible for BOR syndrome was mapped to the long arm of chromosome 8 (6, 7) . By linkage studies of BOR-affected families and molecular analysis of a deletion carried by a patient, this gene was localised to a 7 cM interval between the markers D8S543 and D8S286 (8, 9) . Subsequently, by the characterisation of another deletion associated with an 8q translocation, dir ins (8)(q24.11; q13.3; q21.13) (10), the gene interval was redefined to ∼500 kb (11) . Recently, we isolated the gene underlying BOR syndrome using a positional cloning strategy (12) . This gene was called EYA1 in reference to the strong sequence homology between the 271 amino acid C-terminal *To whom correspondence should be addressed. Tel: +33 145 688890; Fax: +33 145 676978; Email: cpetit@pasteur.fr respectively. For each cDNA sequence, the initiator methionine codon is in bold, the first stop before the initiator codon is underlined and the first codon common to the three cDNAs is circled. The additional exon 1′, present in EYA1B and EYA1C, is indicated by ^, and the nucleotide sequence of the additional exon -1, present only in EYA1C and the corresponding ORF are indicated in lower case and in italics.
region of the predicted protein and the Drosophila eya gene product (69% identity and 88% similarity). Two cDNAs encoding a 559 amino acid protein (predicted mol. wt 61.2 kDa) were reconstructed, and found to differ in the length of their 3′ untranslated region (UTR). The limits of the last nine exons, encoding 317 C-terminal amino acids and the 3′ UTR, were defined and eight mutations subsequently were detected in BOR-affected patients (12) . In addition, two mutations were identified in BO affected patients (individuals presenting with branchial and otic anomalies but without renal anomalies), thus demonstrating that EYA1 also underlies BO syndrome (13) .
We have determined the complete gene structure of EYA1 and report here on the existence of various alternatively spliced transcripts and describe six novel mutations segregating in BOR-affected families.
RESULTS AND DISCUSSION

EYA1 alternative transcripts and gene structure
During the reconstitution of the EYA1 cDNAs, we initially observed two cDNAs differing only in their 3′ UTRs (12) . These cDNAs, isolated from total 9-week foetus RNA, are hereafter referred to as EYA1A (YIO260). Subsequently two additional cDNAs, EYA1B (AJ000097) and EYA1C (AJ000098), were isolated from the same mRNA source (see Materials and Methods) that differed from EYA1A in the 5′ region. EYA1B has an insertion of 128 bp at nucleotide position +25 (the first base of the initiator codon of EYA1A is designated as position +1, Fig. 1 ). EYA1C differs from EYA1B by the replacement of the 5′ region, extending from position -26 to -148, with a 584 bp sequence (Fig. 1) . We previously reported on the cDNA sequence of the murine homologue of EYA1 which had the same 5′ sequence as EYA1A (12) . We (data not shown) and others (14) have identified an alternative murine cDNA sequence which is homologous to EYA1B. Consistent with these various cDNA forms, several bands were observed on northern blots containing human and mouse mRNA (12, 14) . These results suggested the existence of alternatively spliced mRNA transcripts.
To investigate this possibility, we determined the complete gene structure of EYA1. The terminal 3′ exon, exon 16, was identified previously (and referred to as exon H) by partial sequencing of PAC clone 10910 (Fig. 2) . The entire sequence of two adjacent overlapping P1s, 4405 and 9480 (116 kb), known to contain at least part of EYA1 (12) was established and compared with the sequence of the three EYA1 cDNAs. Thirteen exons were determined, of which five, exons 3-7, were newly identified (Fig. 2) . In order to search for the remaining 5′ exons, subclones of the next adjacent PAC clone (11083), were selected by hybridisation with the three cDNAs and analysed (see Materials and Methods and Fig. 2) . A total of four exons were identified. Exon 2 was common to all three cDNAs. Exon 1 was present in EYA1A and EYA1B. Between exon 1 and exon 2, an additional exon was detected, exon 1′, in EYA1B and EYA1C. Another exon, exon -1, located upstream of exon 1, was identified in the 5′ end of EYA1C. Moreover, EYA1C contains only the 3′ part of exon 1; this correlates with the existence of a consensus 3′ acceptor splice site Y n NYAG/G within this exon which could act as a cryptic splice site (15) . All exon-intron junction sequences conform to the GT/AG rule (Table 1) , except intron XII which has a GC donor site. The GT→GC replacement has been reported as the most frequent 5′ splice site variant (16) , and this substitution has been proven to allow correct splicing (17) . The 17 introns vary in size from 0.1 to 27.5 kb. EYA1 has been estimated to extend over 156 kb (Fig. 2 ) (see Materials and Methods). The sequence of the three cDNA isoforms has been derived from several independent cDNA clones and confirmed by genomic sequences. EYA1A is predicted to encode a 559 amino acid protein. The ATG start codon was identified in exon 1 (Figs 1 and 2) within an adequate Kozak consensus sequence (RNNatgY) (18) , and was preceded by a stop codon 71 bp upstream. The additional exon, exon 1′, contained in EYA1B, creates a frameshift resulting in a stop codon in the sequence derived from this exon. Therefore, either this isoform is an untranslated transcript or it is translated using a different start codon. We favour the latter hypothesis, since an adequate Kozak consensus sequence (YNNatgG) was found in exon 1′ preceded by a stop codon 63 bp upstream. This ATG was also proposed as the initiator codon for the alternative cDNA transcript of the murine homologue eya1 (14) . Accordingly, the proteins encoded by EYA1A and EYA1B should differ only in their N-terminal region (Fig. 1) , exon 1 being used as a coding exon in EYA1A and a non-coding exon in EYA1B. The protein resulting from EYA1B is predicted to be 592 amino acids long. In mammals, we know of one situation which is reminiscent of the present one. In the tumour suppressor gene INK4A (also called MTS1 or CDKN2), one exon has been shown to be used in two different reading frames, thus resulting in two unrelated proteins (p16 INK4a and p19 ARF ) (19, 20) . In contrast, the use of overlapping reading frames is very common in viral systems where it is one of the strategies used to create protein diversity (21) . EYA1C has two overlapping open reading frames (ORFs). One of the two predicted ORFs extends from the beginning of the cDNA for 156 amino acids. As this ORF has no methionine initiation codon, this sequence probably extends further 5′. The second ORF is identical to that of EYA1B. However, for this second ORF, the first upstream stop codon is 369 nucleotides distant. Therefore, the two overlapping ORFs of cDNA EYA1C could give rise to two distinct proteins. Alternately, the two ORFs could be translated into a single protein by ribosomal frameshifting. Translational frameshifting has been largely demonstrated in bacteria, yeast and eukaryotic viruses (for a review see ref. 22 ). In humans, translational frameshifting has been described for ornithine decarboxylase antizyme (23) and has been proposed for F18, a newly identified gene (24) .
5′ and 3′ UTR variations and alternate splicing of full-length transcripts are used to generate heterogeneous mRNA populations and suggest multifaceted control of gene expression (25) (26) (27) (28) . In this regard, it would be of particular interest to investigate the spatio-temporal distribution of the different messengers, as well as their encoded protein products during inner ear and kidney development. Human Molecular Genetics, 1997, Vol. 6 
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Mutations in BOR-affected individuals
We previously searched for mutations in the last nine EYA1 exons of BOR patients, and reported eight mutations. In the present study, all EYA1 coding exons were analysed in 20 unrelated BOR-affected individuals, 16 of which were familial cases.
DNA rearrangements. Genomic DNA from BOR-affected patients and their relatives was first analysed by Southern blotting and hybridisation with probes corresponding to each of the 17 EYA1 exons (see Materials and Methods). DNA rearrangements were observed in three families.
In family 14, hybridisation with a probe for exon 9 to Southern blots containing DNA from the two affected individuals resulted in a band shift. Using the sequence data of the EYA1 region, this rearrangement was analysed further. Amplification using a primer specific to a sequence from intron VIII and a primer 9.7 kb downstream in intron IX (see Materials and Methods) resulted in two products: a 10 kb product corresponding to the normal amplimer, and a smaller 4.6 kb product. Sequencing of the smaller fragment identified a 5.6 kb deletion starting from nucleotide position 39 of exon 9 and ending into intron IX.
Hybridisation with probes corresponding to exons 11, 12, 13, 14 and 15 as well as to a sequence of intron X (located 9 kb upstream of exon 11), to Southern blots containing DNA from affected individuals from family 13, resulted in a signal of reduced intensity. Hybridisation with a probe for exon 10 did not result in the reduction of signal intensity, whereas hybridisation with a probe for exon 16 resulted in a band shift. Altogether, these results indicate a distance of 20-37 kb in this family for a deletion extending from intron X to exon 16.
For family 9, in which the mother and daughter are affected, hybridisation with a probe for exon 10 resulted in two additional MspI and TaqI fragments for both patients as compared with control individuals. One of these additional two bands differed in size between the two individuals ( Fig. 3a and b) . Amplification with primers flanking exon 10 (Table 4 ) resulted in a 310 bp fragment, corresponding to the normal amplimer, for both the affected mother and daughter and in an additional fragment of ∼700 and 650 bp respectively. Sequencing of each of these products confirmed that the 310 bp fragment corresponds to the normal sequence of exon 10 and showed that the larger fragments correspond to exon 10 with an inserted Alu element in the opposite orientation. A duplication of 10-16 bp had occurred at the insertion target site, and the 3′ sequence of the Alu element was followed by a long poly(A) tail [the exact length of the duplicated target sequence was indeterminate, owing to the poly(A) tract] (Fig. 3c) . These features correspond to properties of retrotransposition of a non-viral element (29) . The site of insertion was adjacent to a sequence that completely fits the consensus sequence (5′TTAAAA/3′AATTTT) proposed by Jurka as the signal sequence for staggered nicks prior to integration of mammalian retrotransposons (30) . The difference in size between the larger amplified fragments of the mother and daughter was due to a difference in the length of the poly(A) tail, which was reduced from poly(A) 97 to poly(A) 31 when transmitted from mother to daughter. This instability contrasts with a previous report which shows that the polydeoxyadenylate tract of Alu repetitive elements is polymorphic but stable within a given family (31) . The transposition of the Alu element was a de novo insertion as it was not present in the DNA from the maternal grandparents (data not shown). An increasing number of reports Hybridisation with a probe corresponding to exon 10 to Southern blots containing MspI-(a) and TaqI-(b) digested genomic DNA. Note for both digestions the difference in size of the additional band for both the mother and daughter [sequencing revealed that this was due to a difference in the length of the poly(A) tract]. The transposed Alu element is flanked by a direct repeat and the insertion site is adjacent to a 5′ nicking signal sequence (with respect to the orientation of the Alu element) (underlined) described by Jurka (30) .
have shown that the transposition of Alu elements, as well as that of L1 or other mobile elements, is a source for mutations which give rise to genetic diseases (32) (33) (34) (35) (36) (37) (38) (39) . The comparison of the newly inserted Alu element with a database for repeated elements (Pythia) showed that it belongs to the Sb1 Alu subfamily. This subfamily, which corresponds to one of the most recent evolutionary branches of Alu elements (40) , is transcriptionally active (41) . The insertion of mobile elements is likely to result in exon skipping, as demonstrated by other reports (37) (38) (39) .
Point mutations. Sequence analysis of the EYA1 coding exons, starting from exon 1 to 16, was carried out on 20 unrelated affected individuals. When a mutation was detected, the corresponding exon of other available affected family members was sequenced. Seven single base changes, corresponding to silent polymorphisms (Table 2) , and three point mutations were detected. Nomenclature used is as described in (49) . Nucleotide position +1 corresponds to the first base of the initiation codon of the cDNA EYA1A, except for exon 1′, in which nucleotide position +1 corresponds to the first base of the initiation codon of the cDNA EYA1B. Nomenclature used is as described in (49) . For consistency with our previous reports (12, 13) , nucleotide position +1 corresponds to the initial base of the initiation codon of EYA1A, and amino acid position +1 corresponds to the initiation codon of EYA1A. In families 7 and 13 one non-penetrant carrier was observed out of four and five carriers for each family respectively. a (12); b (13).
In family 10, all affected members carried a G→C transversion at the +5 position of the intron XV splice donor site. This transversion was not observed in the sequences from 50 unaffected control individuals. Moreover, several reports have described replacement of the G in position +5 of splice donor sites in different genetic diseases, thus suggesting that mutations at this position prevent normal splicing of the upstream exonic sequence (42) (43) (44) (45) . Therefore, this mutation is likely to be responsible for the disease by impairing normal splicing of the penultimate exon.
In family 7 and family 24, a missense mutation was detected in all affected members. In family 7, the mutation resulted in a Ser→Pro substitution at codon 454 (TCG→CCG) in exon 13 (mutation S454P). In family 24, the mutation resulted in a Leu→Arg substitution at codon 472 (CTC→CGC) in exon 14 (mutation L472R). These two substitutions were absent in the 50 control individuals. S454P and L472R produce dramatic changes by introducing amino acids with different hydropathy. Moreover, the targeted serine residue is conserved among the EYA1 gene products of man and mouse, as well as the eya gene product of Drosophila, and the targeted leucine residue is common to all the eya family members isolated so far (12, 14) . Therefore, S454P and L472R are likely to give rise to the disease, suggesting that these two serine and leucine residues, of the eyaHR, are essential for the structure and/or function of the EYA1 protein.
Sequence analysis of the coding region, including splice site junctions of EYA1, as well as Southern blot analysis of the coding region and the 5′ and 3′ UTRs, failed to detect anomalies in 14 of the 20 patients. Among these 14 patients, 10 represented familial cases and, for six of them, linkage analysis was consistent with the involvement of EYA1 (8) . Since no evidence for genetic heterogeneity has ever been reported, we assume that, for these 14 patients, the mutations lie either in the promoter region, within an intron, in the 3′ UTR or in the most 5′ sequences which have not yet been studied extensively. Figure 4 and Table 3 summarise all the mutations we have detected in BOR-and BO-affected families to date. All the reported 14 mutations are different, demonstrating the heterogeneity of mutations in BOR-affected patients. Nevertheless, all the mutations occurred in exons belonging, or immediately adjacent, to the eyaHR [also called Eya box (14) ]. This clustering of mutations in the eyaHR, which represents half of the coding sequence, is intriguing. Mutations outside this domain may either give rise to a lethal defect or to a discrete undetected phenotype. We favour the latter hypothesis for the following reasons: one of the two patients carrying a deletion of the whole gene was exclusively affected by BO syndrome (11, 46) , and the only mutation that has been detected outside the eyaHR was also present in a BO-affected patient (13) . Based on these observations, we hypothesise that most of the mutations detected in BOR patients could act as dominant-negative mutations. The clustering of mutations in eyaHR delineates the crucial role of this highly conserved domain and will guide further functional studies of the EYA1 protein.
MATERIALS AND METHODS
Patients
Clinical studies of BOR families were previously described (8) .
cDNA isolation
Oligo(dT) and random primed cDNA populations were generated from total 9 week human foetus poly(A) + RNA, and amplified using the marathon cDNA amplification kit (Clontech) according to the manufacturer's recommendations. Specific primers for the 5′ RACE-PCR were EYA30R3.2: 5′ GAATGAGCGAGAGTGCT-TTCAGGGCCAGTG 3′, specific to exon 13, for the first amplification, and 30BR2 nest: 5′ CAGCCAGGCTTCCCTCT-TAGCTGGACCA 3′, a nested primer also specific to exon 13, for the second amplification. Primers for the 3′ RACE-PCR were 26F3: 5′ CCACTCCTTGCTTACTGGGTCCTACGCCAA 3′, specific to exon 9, for the first amplification, and EYA30BF2 nest: 5′ TGGTCCAGCTAAGAGGGAAGCCTGGCTG 3′, a nested primer specific to exon 13, for the second amplification. In order to isolate the complete 5′ sequence for each cDNA isoform, 5′ RACE-PCR amplifications were performed using the PCR primer EYA30R3.2, and the second amplification was performed with the primers NEYAKnest: 5′ GAGGAAACAGCAACATCTGAACT-GGCTTGAG 3′, specific to exon 2 and present in all the cDNA isoforms.
Exon positions and intron-exon boundaries
Two overlapping P1s, 4405 and 9480, mapping to the centre of the gene interval were sequenced as described (12) . To determine the intron-exon boundaries, genomic DNA sequences of the two P1s were compared with the EYA1 cDNA sequences. Subclones of the adjacent PACs 11083 and 10910, containing the 5′ and 3′ exons respectively, were identified by hybridisation with subclones of the EYA1 cDNAs. Exon-intron boundaries, and the intronic sequences flanking each exon, were determined by sequencing positive subclones with primers derived from the EYA1 cDNA sequences. Intronic sequences flanking the exons are available upon request. The distance between these exons was deduced from either the assembled contig of genomic sequences of the P1s 4405 and 9480, or by long-range PCR for the exons lying outside this contig [performed using the Boehringer Mannheim Expand PCR system as described (47)].
Southern blot analysis
Southern blots containing EcoRI-, MspI-, PstI-or TaqI-digested DNA, from both familial and sporadic cases, were prepared according to standard techniques. In order to detect possible DNA rearrangements in BOR-affected patients, 14 probes covering the entire EYA1 cDNA were derived by PCR amplification and hybridised to the Southern blots.
Genomic PCR amplification and DNA sequencing
For the detection of point mutations, two sets of specific primers were chosen in the intronic sequences flanking each exon at a distance of at least 60 bp from the corresponding exon-intron junction (Table 4) . PCR amplification and DNA sequencing conditions were as described (48) . In order to determine the extent of the deletion carried by the affected individuals of family 14, long-range PCR was carried out as described above using the forward primer from the intronic sequence of exon 9 (Table 4 ) and primer 24R: 5′ TCTACAATCAATCCTCCCTC 3′ as the reverse primer.
